Formation of multiprotein complexes on cellular membranes is critically dependent on the cyclic activation of small GTPases. FRAP-based analyses demonstrate that within protein complexes, some small GTPases cycle nearly three orders of magnitude faster than they would spontaneously cycle in vitro. At the same time, experiments report concomitant excess of the activated, GTP-bound form of GTPases over their inactive form. Intuitively, high activity and rapid turnover are contradictory requirements. How the cells manage to maximize both remains poorly understood. Here, using GTPases of the Rab and Rho families as a prototype, we introduce a computational model of the GTPase cycle. We quantitatively investigate several plausible layouts of the cycling control module that consist of GEFs, GAPs, and GTPase effectors. We explain the existing experimental data and predict how the cycling of GTPases is controlled by the regulatory proteins in vivo. Our model explains distinct and separable roles that the activating GEFs and deactivating GAPs play in the GTPase cycling control. While the activity of GTPase is mainly defined by GEF, the turnover rate is a sole function of GAP. Maximization of the GTPase activity and turnover rate places conflicting requirements on the concentration of GAP. Therefore, to achieve a high activity and turnover rate at once, cells must carefully maintain concentrations of GEFs and GAPs within the optimal range. The values of these optimal concentrations indicate that efficient cycling can be achieved only within dense protein complexes typically assembled on the membrane surfaces. We show that the concentration requirement for GEF can be dramatically reduced by a GEF-activating GTPase effector that can also significantly boost the cycling efficiency. Interestingly, we find that the cycling regimes are only weakly dependent on the concentration of GTPase itself.
A large variety of cellular processes, such as the formation of filopodia or transport vesicles, require that large protein complexes are precisely positioned on intracellular membranes to execute a specific task and then are promptly disassembled to perform their function elsewhere. Small GTPases play a major role in the spatiotemporal control of these complexes. Their function is based on the unique property of cycling between the active GTP-bound state, in which they enable complex formation, and the inactive GDP-bound state, which promotes complex dissolution. Recent experiments based on fluorescence recovery after photobleaching have found that some small GTPases rapidly cycle within protein complexes, causing continuous release and recruitment of the complex components. The seemingly futile cycling is accompanied by a large excess of the active form. This puzzling behavior challenges one's intuition and calls for the application of quantitative methods. Here, Goryachev and Pokhilko use computational modeling to identify regulatory mechanisms that could enable GTPases to cycle with the experimentally observed frequency and efficiency. They show that to achieve high activity and turnover simultaneously, the concentrations of the regulatory molecules that control GTPase cycling should be tightly maintained within the optimal range.
Citation: Goryachev AB, Pokhilko AV (2006) Computational Model Explains High Activity and Rapid Cycling of Rho GTPases within Protein Complexes. PLoS Comput Biol 2(12): e172. https://doi.org/10.1371/journal.pcbi.0020172
Editor: Diana Murray, Weill Medical College of Cornell University, United States of America
Received: May 1, 2006; Accepted: October 9, 2006; Published: December 1, 2006
Copyright: © 2006 Goryachev and Pokhilko. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Agency for Science, Technology, and Research of Singapore.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: GAP, GTPase activating protein; GDI, guanine nucleotide dissociation inhibitor; GEF, guanine nucleotide exchange factor; RD, GDP-bound GTPase; RT, GTP-bound GTPase
The Ras superfamily of small GTPases  has recently emerged as the central element of a variety of molecular modules that provide spatial and temporal control for protein complex formation in the cell [2–4]. The operation of these ubiquitous control modules is based on the intrinsic property of GTPases to cycle between an inactive GDP-bound state (RD) and an active GTP-bound state (RT). The biological function of GTPases is performed only by the active form that binds and activates a broad range of effector proteins . Many of the effectors, such as WASP  and CNK1 , are scaffold-like proteins that change their conformation and gain the ability to recruit several binding partners while they are associated with the RT. Such effectors serve as platforms for the assembly of functional multiprotein complexes. Once brought together by the GTPase-controlled scaffolds, these complexes perform structural and signaling functions crucial for cell existence, for example, actin polymerization [8,9] and activation of the p38 MAP kinase pathways [7,10].
Since the cellular localization and timing of the existence of these complexes are determined by the local availability of the RT, a simultaneous sharp increase in the local GTPase concentration and the relative abundance of its active form are expected in the hotspots of complex formation. Owing to recent advances in imaging techniques , such a highly localized cellular distribution of the RT was indeed observed in several in vivo systems, e.g., for cdc42 in the extending filopodia of fibroblasts  and in emerging yeast buds . In the intracellular environment, GTPases are tightly controlled by multiple regulatory proteins. GTPase activating proteins (GAPs) inhibit the GTPase activity by accelerating hydrolysis of GTP into GDP. The activation of GTPases is catalyzed by guanine nucleotide exchange factors (GEFs) that facilitate the replacement of GDP by GTP. One would expect that to control complex formation, it is sufficient to simply segregate the activity of GEFs and GAPs spatially and/or temporally. Some small GTPases indeed appear to follow this strategy. For example, activation of the Arf family of GTPases by their cognate GEFs reversibly changes their conformation to simultaneously enable binding to the effectors and to lipid membranes . Activated GTPases then anchor to a membrane and recruit specific effectors, such as coat proteins COP I and COP II . Once the nascent fragment of coat is solidified by the protein–protein interactions between coatomers, GAPs deactivate Arf GTPases and return their conformation to the binding-incompetent form, thus preparing for the vesicle uncoating and release of coatomers and GTPases back to the cytoplasm . Within this framework, Arf molecules were thought to undergo a single activation cycle per coat formation. Such a mechanism would seem to provide the necessary complex-control function at a low energetic cost (each cycle consumes one GTP molecule).
Therefore, it came as a surprise  that some GTPases perform rapid, seemingly futile, cycles of GTP hydrolysis within respective GTPase-controlled complexes. In their seminal work published a decade ago, Zerial and colleagues using biochemical methods discovered that Rab5 vigorously converts GTP into GDP in the absence of vesicle fusion. Recent FRAP-based studies [13,18,19] confirmed this early observation and furthermore demonstrated that, driven by cycling of GTPases, the GTPase-controlled protein complexes rapidly dissolve into the cytoplasm and reassemble on the membrane with a half-life of ∼1–5 s. Only such a dynamic exchange between the free cytoplasmic proteins and the complexes on the membrane can explain the rapid fluorescence recovery observed in these experiments. To account for these observations, the respective GTPases must cycle within protein complexes at least two orders of magnitude faster than they spontaneously cycle in vitro (see an estimate for cdc42 in Results).
Combining these experimental data with the requirement for the activated form RT suggests that within protein complexes these GTPases cycle both efficiently and rapidly, maintaining a significant excess of the active form while keeping a high turnover rate. This phenomenon is still poorly understood and cannot be explained simply by the relative excess of GEFs over GAPs or by the spatiotemporal segregation of their activity. While separate effects of GEFs and GAPs are thoroughly studied and the kinetic parameters for some well-characterized systems are determined [20–22], the understanding of the interplay of various regulators in the control of GTPase cycling is still lacking. In particular, little is known about the concentrations of GTPases and regulatory molecules that are required to achieve experimentally observed cycling rates and efficiency. The situation is further complicated by the potential involvement of other proteins, such as guanine nucleotide dissociation inhibitors (GDIs)  and the GTPase effectors themselves.
In the more developed field of G proteins, a large body of experimental [24–26] and theoretical [27–30] work was done to understand how the amplitude and the duration of G protein signaling are controlled by G protein–coupled receptors (GEFs) and GAPs. This analysis revealed intricate regulatory relationships within the GEF–G protein–GAP module and suggested that variation in the concentrations of its components may define the specific signaling phenotypes . Although G proteins and Ras GTPases are similar in the principle of their operation as molecular switches, they differ in both molecular structure and cellular function. Therefore, it is logical to expect that the control of their cycling would also demonstrate divergent features. Given the critical role that small GTPases play in the regulation of a plethora of cellular functions [31–34], analysis of their control deserves special attention.
Here we use computational modeling to identify regulatory mechanisms that could enable GTPases to cycle with the frequency and efficiency observed in the FRAP-based experiments. We assume a kinetic mechanism in which GTPases cycle while localized on the membrane. For the type of GTPases considered in this work, both RT and RD have high affinity to the membrane; however, the RD form is subject to rapid GDI-mediated membrane–cytoplasm exchange . The counteracting transport processes that depose inactive GTPases on the membrane and return them back to the cytoplasm are thought to be much faster than the rate-limiting GTPase cycling and are not considered here explicitly. Leaving the cytoplasmic GTPase pool and the membrane–cytoplasm transport beyond the scope of the present study, we instead vary the total concentration of the GTPase on the membrane as a model parameter. We also assume that the membrane-anchored GTPases are equally accessible to GEFs and GAPs that are concurrently present on or near the membrane. This mechanism is distinct from the earlier described “Arf-type” mechanism in which only the RT is membrane-bound while RD is strictly cytoplasmic and GEFs are spatiotemporally segregated from GAPs.
Although presently it is not yet feasible to map kinetic mechanisms onto the GTPase families, the mechanism adopted here appears to best describe the cycling dynamics of Rho and Rab GTPases [5,36]. In addition, the majority of the existing experimental data on the rapid cycling of GTPases within protein complexes comes from the same two families. Of these, members of the Rho family, such as cdc42, Rho, and Rac), have been characterized in greater biochemical detail. Therefore, we chose the Rho family of GTPases, in particular its yeast member cdc42p, as a prototype for our model and used the corresponding kinetic parameters to define the model quantitatively (see Methods).
Through a detailed kinetic analysis of the model, we demonstrate that a fast turnover and a high activity of the GTPase can be achieved together only within a specific concentration range of GEF and GAP. The estimated values of these concentrations indicate that the efficient cycling control requires an environment of dense protein complexes. We further extend the analysis by investigating the contribution of a hypothetic scaffold-like GTPase effector that can form a complex with the GEF and amplify the GEF's nucleotide exchange activity while bound to the RT. We demonstrate that such an effector can dramatically enhance GTPase performance and explain the existing experimental data.
The GTPase Control Module
We developed a mathematical model to describe how the GTPase cycle is regulated by a generic GEF (E) and GAP (A). We reconstructed the core reaction mechanism as shown in Figure 1 on the basis of the analysis of published experimental data. The fundamental GTPase cycle consists of three states: RD, RT, and a short-living nucleotide-free form R. Each of the three states can bind E or A, which catalyze the respective transitions of the GTPase cycle. To simulate the in vivo conditions, concentrations of GTP and GDP were fixed at the levels that are thought to be representative of the intracellular environment (see Methods for details). The resulting reaction scheme of the complete control module consists of 11 species (nine intermediates and free E and A), and their reactions are shown by arrows in Figure 1. The total concentrations of the GTPase, GEF, and GAP, denoted as R0, E0, and A0, are the model parameters that were varied over a broad range to discover all biologically relevant regimes of cycling control.
The three forms of the GTPase (RD, RT, and nucleotide-free R) (middle layer) form complexes with a GEF (E) (bottom layer) and a GAP (A) (top layer). Solid arrows indicate the main reaction fluxes. All reactions except GTP hydrolyses (2 → 1, 6 → 8, 5 → 3) are reversible. Numbering of the species is consistent with the reaction rate constants listed in Table 3. Free GTP (T), GDP (D), GEF, and GAP are not shown for simplicity.
GTPases Spontaneously Cycle In Vitro
In the absence of any regulatory molecules, the reaction scheme is given by the middle level in Figure 1 and represents a simple cycle with three states. If the GTP/GDP ratio is taken far from the equilibrium value, e.g., equal to that of a cell, the nucleotides provide a thermodynamic force that drives the GTPase cycle. In the stationary state, all three state fluxes are equal to , which takes the value 9.67 · 10−3 min−1 with our model parameters. Further calculations show that the GTPase activity and recovery time in this stationary state are 0.483 and = 35 min, respectively (see Methods for the definitions). Completion of the entire cycle takes 1.5 h with the cycling period TC = 100 min. This spontaneous dynamic of a GTPase demonstrates an example of a very inefficient cycling characterized by nearly equal amounts of active and inactive form and a turnover rate incompatible with intracellular processes. Although devoid of biological function, the spontaneous cycling of the GTPase provides a useful baseline for comparison with regulated cycling in vivo.
GEFs Alone Have Little Effect on GTPase Turnover
We first asked how a single GEF, unaided by other regulatory molecules, influences GTPase cycling. The reaction scheme in this partial control scenario is represented by the middle and bottom levels of the complete diagram in Figure 1. To address the above question, we analyzed model behavior in a broad range of GTPase and GEF concentrations (1 nM–1 M) (Figure 2). At a constant R0, GTPase activity shows a characteristic biphasic response to the increase in the GEF concentration (Figure 2A). First the activity rises, starting from the level of the control-free regime 0.483, reaches its maximum 0.958 at E0 = 250 μM, and subsequently decreases to zero. A detailed analysis of the reaction fluxes shows that the proportion of the GTPase that cycles without dissociation from the GEF continuously increases as E0 grows. This GTPase fraction becomes trapped in a futile cycle 3 → 4 → 5 → 3 at the bottom of the reaction scheme and no longer participates in the processive cycle 1 → 3 → 4 → 5 → 2 → 1. This explains the decrease in the apparent GTPase activity with the increase in E0. Surprisingly, the model predicts that in the physiologically relevant range of GTPase concentrations (up to ∼10 mM), the profile of the GTPase activity does not depend on R0. An important consequence of this prediction is that the same, fairly high concentration of the GEF is necessary to maximize the activity of the GTPase regardless of its total concentration.
The values of the GTPase activity (A), recovery time (B), and performance index (C) are shown as functions of the total concentrations of the GTPase (R0) and GEF (E0). The model predicts that in the physiologically relevant range of the GTPase concentrations (R0 ≤ 10 mM) all three characteristics do not depend on R0. Roman numerals on the contour plot of the performance index P denote three regions with distinct GTPase cycling regimes: (I) effectively control-free, (II) processive (P > 0.1, highlighted in light grey), and (III) futile cycling within the complex with the GEF. Numbers on the contour lines indicate the levels of P.
The profile of the performance index P shown in Figure 2C highlights the existence of three distinct regimes of the GTPase cycling: (I) effectively control-free regime with the main cycle 1 → 9 → 2 → 1, (II) processive regime 1 → 3 → 4 → 5 → 2 → 1, and (III) GEF-chaperoned regime 3 → 4 → 5 → 3. Only within the intermediate processive regime is the cycling control efficient and does it result in a significant increase in GTPase activity. At the same time, the turnover rate of GTPase in the GEF-only system is at most twice that of the control-free GTPase. As follows from Figure 2B, the GTPase recovery time is bounded between the control-free value of = 35 min and the minimum of 17 min that is reached at saturating E0. This result demonstrates that the experimentally observed rates of GTPase turnover cannot be explained solely by the activity of GEFs.
GAP Is Necessary for the High GTPase Turnover Rate
Introduction of a GAP into the reaction scheme brings about profound changes in the operation of the GTPase control module. Simulation of the complete GEF–GAP reaction scheme reveals a regime with high GTPase activity at large GEF and small GAP concentrations (see Figure 3A). Comparison with Figure 2A shows that the addition of a GAP results in the expected erosion of the activity peak and its shift toward higher E0 as A0 increases.
The profiles of the GTPase activity (A), recovery time (B), and performance index (C) are plotted as contour lines. While activity remains largely a function of the GEF concentration, the recovery time is determined mostly by the GAP concentration. Performance maximum with the activity 85% and recovery time ∼3 min is attained at E0 = 0.78 mM and A0 = 0.66 μM. Further increase in the turnover rate can be achieved at the expense of activity. Numbers on the contour lines indicate the levels of the respective characteristics. Total GTPase concentration is R0 = 1 mM.
Strikingly, the model predicts that the GTPase turnover rate quantified by the recovery time τRT is almost exclusively a function of the GAP concentration (Figure 3B). τRT exhibits some dependence on E0 only at very large GEF concentrations, which are likely beyond the physiologically relevant range. This result suggests that GAP is the main factor that determines the observed in vivo fast turnover rates of the GTPase-controlled complexes.
The profile of the performance index (Figure 3C) has a single broad maximum centered at E0 = 0.776 mM and A0 = 0.66 μM. At these optimal concentrations of GEF and GAP, the recovery time, τRT = 3 min, is more than ten times shorter than in the control-free system and is accompanied by a high activity of 0.85. Further reduction in the recovery time can be achieved by increasing the GAP concentration, however, at the expense of GTPase activity.
Importantly, we find that profiles of activity, recovery time, and performance index are virtually insensitive to the concentration of the GTPase itself. At R0 = 1 μM, which is three orders of magnitude lower than the total concentration of the GTPase in Figure 3, the maximum of P shifts to = 0.631 mM and = 0.19 μM, while the values of all performance characteristics remain essentially the same.
In the Efficient Regime, the GEF–GAP Control Module Can Be Reduced to a Single Cycle
In search for the mechanism that provides an increased efficiency and cycling rate in the GEF–GAP system, we analyzed the reaction fluxes at varied concentrations of GEF and GAP. We noticed that at large E0 and A0, only a subset of fluxes (shown by thick solid arrows in Figure 1) is significant, while the remaining fluxes have negligible values. To test the hypothesis that only the main fluxes are important for efficient functioning of the GTPase control module, we introduced a reduced model in which only the subset of significant fluxes was retained. Analysis of the complete model showed that it always possesses only one stable steady state and thus we do not risk losing a steady state by reducing the complete model. Rigorous comparison of the complete and reduced models demonstrated that in the (A0, E0) domain with efficient cycling control, where both the GTPase activity and the turnover rate are high, the flux vectors of the reduced and complete reaction schemes differ by less than 5% (see Methods). The difference between the two models continuously diminishes as the total concentrations of GAP and GEF increase. Neglecting the fluxes, which are nonessential at large E0 and A0, results in a simple, biologically intuitive reaction scheme. Thus, the reduced model shows that in the efficient regime the operation of the GEF–GAP control module is based on two linear pathways: the GEF arm 1 → 3 → 4 → 5 → 2 and the GAP arm 2 → 6 → 8 → 1. These pathways catalyzed by the GEF and GAP effectively short-circuit the nonessential parasitic reactions that slow down the GTPase cycling. The cycle formed by the union of the two pathways is, in fact, the fastest GTPase cycling loop with the period TC = (k13E)−1 + (k26A)−1 + 0.2 min, where the constant term is the sum of the inverse first-order rate constants in the cycle. Note that the actual value of TC is a function of concentrations of the free GAP and GEF, which grow together with the respective total concentrations.
The reduction of the model to a single loop allowed us to derive some analytical estimates for the activity and recovery time (see Methods for derivation). These estimates are useful for the interpretation of the above results. Thus, a straightforward calculation shows that the GTPase recovery time is a sole function of the free GAP concentration in complete agreement with the simulation results. Comparison of the numerically simulated and analytically computed recovery times (see Methods) shows that this estimate for τRT is valid in a very broad range of (A0, E0), the total concentrations of GAP and GEF, respectively. We also derived an estimate for the GTPase activity which closely approximates the numerically simulated results and explains the biphasic dependence of the activity on the concentration of GEF (see Methods for definitions of constants). Comparison of the two derived estimates highlights the nature of the conflict between the activity and the turnover rate. While a decrease in τRT requires a larger A, an increase in the activity demands a lower free GAP concentration.
Scaffold Effector Can Significantly Boost the Performance of GTPase Cycling
Comparison of the above results with the experimental data suggests that additional levels of control may be involved to enable the observed rapid cycling rates without a significant loss in GTPase activity. Potential candidates for this role are GTPase effectors that bind a GEF and increase its activity. Indeed, in a number of molecular modules reported in recent literature, a scaffold-like effector has been found in the complex with the active GTPase and its GEF . Importantly, for some of these effectors, such as intersectin-l  and Rabaptin-5 , it has been quantitatively shown that, as long as the effector stays in complex with the RT, the activity of the bound GEF increases several fold. For further analyses we assumed that scaffold-effector S forms a stable complex E* with the GEF E at all times [39,40]. Binding of the E* to the RT results in the formation of an activated tripartite complex M (RT-S-E) whose activity is substantially higher than that of the original GEF E. A detailed kinetic analysis of the complete reaction scheme that includes all possible reactions of the complex E* would require the introduction of nine intermediates (·)E*(·), where (·) stands for any of the RD, RT, or R, and the knowledge of an additional 54 reaction rate constants. Since at the present moment none of the known scaffold-effector systems has been characterized at this level of kinetic detail, we resorted to a coarse-grained modeling approach that requires only three additional rate constants. Based on the experimental data for several GTPase effectors [41,42], we estimated the rate constants for the formation k2M = 600 μM−1min−1 and dissociation kM2 = 18 min−1 of M (M ↔ RT + E*) and represented the activity of M as a single catalytic step RD + M → RT + M with effective second-order rate k12 = 0.6 μM−1min−1.
Simulation of our model demonstrates that scaffold-effector S significantly increases the performance of the GTPase control module. Comparison of Figures 3 and 4 shows that, while the recovery time does not change noticeably, the GTPase activity is considerably enhanced. This enables a high GTPase activity at the large GAP concentrations where the recovery time is short. For example, at = 100 μM and A0 = 40 μM, the model predicts the GTPase activity 0.72 and the recovery time 3.2 s.
The profiles of the GTPase activity (A), recovery time (B), and performance index (C) are plotted as contour lines. Note the increase in the area of the optimal control and its shift toward lower GEF concentrations in comparison with Figure 3C.
Importantly, our model suggests that the involvement of a GEF-activating scaffold-effector substantially reduces the optimal concentration of a GEF. Thus, the maximum of the performance index is located at = 27.9 μM, which is more than 20 times smaller than the corresponding value in the system without M. In a stark contrast with the GEF–GAP module, performance of the M–GAP system scales with the total concentration of GTPase. As follows from Table 1, the values of the activity and recovery time computed at the maximum of the performance index improve with an increase in R0.
Here we quantitatively investigated how the cycling dynamics of a small GTPase are controlled by GEFs and GAPs. Although our model is predominantly based on the Rho family of GTPases, it is mechanism- rather than molecule-specific. Under the assumptions of our model, GTPases can freely cycle and form complexes with effectors and regulatory GEFs and GAPs while remaining anchored to the membrane. According to the existing FRAP data, this “Rho-type” mechanism is exhibited by at least some members of the Rho and Rab families, such as cdc42 , Rac2 , and Rab5 . Future research will undoubtedly identify more small GTPases that follow this mechanism as well as likely reveal more functional patterns of GTPase cycling, distinct from both “Arf”- and “Rho”-type mechanisms.
To elucidate the individual roles of regulatory proteins as well as their synergistic action, we compared several possible designs of the control module with progressively increasing complexity. Characterizing the stationary activity of the GTPase and its turnover rate as either high or low, one can distinguish up to four qualitatively distinct regimes of cycling. Of these we concentrated on the regime with high activity and high turnover rate since this is the only regime that is relevant for the rapid recovery of fluorescence observed in the FRAP-based studies described here. The fundamental question that we sought to address is how GTPase cycling is controlled so that high activity is achieved in parallel with a rapid turnover.
A convenient baseline for this analysis is provided by the spontaneous cycling of a GTPase in a chemostat with the intracellular concentrations of GTP and GDP. Under these control-free conditions, yeast cdc42p would cycle with the basal activity of ∼0.5 and the turnover rate nearly three orders of magnitude lower than the rate observed in the emerging bud . In vivo, this slow “parasitic” cycling is thought to be prevented by GDIs that sequester the inactive form of the GTPase and block it from shedding the GDP . Several lines of evidence suggest that GDIs play an important role in the transport of GTPases between cellular compartments . However, once a GTPase molecule is localized on the membrane, its cycling is not appreciably affected by GDIs , and GDI knockouts often show no changes in GTPase functions [35,44]. Since transport processes are left outside the scope of the present analysis, we did not consider the influence of GDIs on GTPase cycling.
Analysis of the three plausible designs of the cycling control module represented by a single GEF, a GEF–GAP module, and its modification with a GEF-activating GTPase effector have revealed a number of common trends. We demonstrated that GEF and GAP play distinct and separable roles in cycling control. While the activity of GTPase in a stationary state is mainly defined by the activity of the GEF, the turnover rate, which is inversely proportional to the GTPase recovery time, is almost entirely a function of the free GAP concentration. Our model shows that in the absence of a GAP, GEF alone can only marginally increase the turnover rate. Combined action of GAP and GEF amplifies the turnover of the GTPase and reduces the recovery time by at least one order of magnitude. The involvement of a scaffold-effector that increases the activity of a GEF can significantly improve the GTPase cycling performance by boosting both the activity and turnover rate. This additional level of control reduces the recovery time by another order of magnitude, bringing it into the range reported in FRAP experiments.
In the field of G protein signaling it has been observed that GAPs accelerate the termination of signaling without reduction of the signal amplitude [24,25]. We found that the maximization of the activity and turnover rate of a small GTPase impose conflicting requirements on the GAP concentration. While the activity is always reduced by the GAP, the turnover rate grows proportionally to the GAP concentration. Therefore, to achieve a high activity and turnover rate at once, the concentrations of GEF and GAP should be tightly controlled to remain within the optimal range. Based on the contradictory nature of the requirement for the GAP, we predict that future experiments will reveal two distinct subclasses of the GTPase-controlled systems: optimized for high turnover rate and for high activity. Cycling regimes of a small GTPase are found to be less dependent on its total concentration than the activity of G proteins on the G protein concentration . For the GEF–GAP module, our model predicts that and , the optimal total concentrations of GEF and GAP, are almost insensitive to the variation of the GTPase concentration, R0. As R0 increases by three orders of magnitude, modestly rises ∼3.5-fold, while remains virtually the same. On the contrary, the performance of the modified M–GAP module steadily increases with the GTPase concentration (Table 1). This difference can be potentially utilized to experimentally distinguish the two designs of the control module.
Similar to the control of G protein signaling , concentrations of GAP and GEF were identified as the major factors that determine the character of the cycling regime. Our results indicate that for the GEF–GAP module to provide acceptable GTPase activity and turnover rate, the total concentration of the GEF should be on the order of 1 mM. Such high concentrations are possible only within dense protein clusters assembled on the membrane. For comparison, a compact hexagonal packaging of spherical protein complexes with diameter 10 nm would result in an effective 1.93 mM concentration of its components in a 10-nm-thick layer of the cytoplasm above the membrane surface. Reduction of this concentration requirement by an effector-scaffold, which was demonstrated here for the M–GAP module, allows for sparser clusters. It is also tempting to speculate that for certain low-abundant GEFs, the co-option of such effectors may provide a vital mechanism that enables effective control over the respective GTPases despite a low cellular copy number. These hypotheses may offer some insight into why GEF-effector complexes are increasingly found as a recurring motif of the complex-formation control modules . Thus, apart from the quantitatively characterized cases of intersectin-l and Rabaptin-5, the increase in the GEF activity has been observed in the yeast complexes Sec4p[GTPase]-exocyst[effector]-Sec2p[GEF]  and Ypt7p[GTPase]-Vps/HOPS[effector]-Vps39p[GEF] [46,47]. Although all GTPases in the above examples belong to either Rho or Rab families, the phenomenon of a GEF-activating GTPase effector is likely not restricted to these two families only. Thus, Sos is simultaneously an effector and a GEF for Ras GTPase . In this peculiar case, the roles of the effector and the GEF are performed by two different domains of the same protein. It is conceivable that Sos evolved as a fusion of two originally independent proteins. Regardless of the molecular implementation, the function of all GEF-activating effectors is to provide a positive feedback loop that increases the cooperativity of GTPase activation.
Our results indicate that maintaining optimal concentrations of regulatory proteins in the focus of complex formation is the key factor for achieving efficient GTPase cycling. Since these concentrations are typically several orders of magnitude higher than the respective cytoplasmic concentrations, powerful mechanisms must be in operation to recruit regulatory molecules to the membrane. Several candidate mechanisms based on protein–lipid [49,50] and protein–protein interactions [51,52] have been identified and require further investigation. These mechanisms often form the basis for positive and negative regulatory feedback loops [53,54] and are likely to increase the cooperativity of protein complex formation. The integration of these upstream mechanisms with the GTPase control module will result in more realistic models of GTPase-controlled complex formation and bring a better understanding of a great variety of cellular processes that depend on cycling dynamics of small GTPases.
Model formulation and rate constants.
We formulated the chemical kinetics corresponding to the scheme shown in Figure 1 as a system of 11 mass-action rate law equations with 27 rate constants. For example, the equation describing the time evolution of RD is
Detailed formulation of each model equation is given in Table 2, which also contains an equation for M, the complex of RT and E*. Concentrations of nucleotides were considered constant and equal to the average cell concentrations typically reported in the literature : 500 μM for GTP (T) and 50 μM for GDP (D). Depending on the type and state of the cell, these concentrations may vary and cause a slight alteration of all reaction fluxes since the thermodynamic force that drives GTPase cycling depends on the logarithm of the GTP/GDP ratio . However, if such a variation is within biologically meaningful limits and does not lead to the breakdown of cellular homeostasis, it does not affect any of the qualitative conclusions of this study.
Reaction Rate Constants Used in the Model Simulations
Where available, rate constants were derived from the in vitro data for the yeast cdc42p. Remaining constants were estimated from the published experimental data on other small GTPases of the Rho family. Rate constants were further constrained by fitting the model to the available data for the yeast cdc42p (Figure 5). The values of the rate constants together with their sources are summarized in Table 3.
(A) Kinetics of GDP dissociation from [3H]GDP-bound cdc42p after mixing with GTP. Comparison of the model simulations and experimental results  is shown as groups a and b for the reactions with and without GEF cdc24p, respectively. Concentrations of cdc42p, cdc24p, and GTP were 90 μM, 28 μM, and 100μM.
(B) Simulation of GAP-stimulated GTP hydrolysis by cdc42p. Experimental data are for the yeast GAP Bem3 . GTP hydrolysis was essayed by measuring phosphate (Pi) release over 5 min. Initial concentration of [γ-32P]GTP-bound cdc42p was 0.1 μM. Simulation results are shown by solid lines.
Starting from arbitrary initial conditions, the reaction scheme in Figure 1 relaxes to a stationary state characterized by a time-independent set of stationary concentrations and generally nonzero reaction fluxes. A transition reaction flux Jlm that connects species l and m can be readily calculated from the species concentrations and the rate constants, e.g., flux J13 connecting RD and RDE (see Figure 1) is The sign of Jlm defines the flux direction. For each node i of the reaction scheme, we can compute the influx , the sum of all transition fluxes that enter the node, and the efflux , the sum of all outbound fluxes. In the stationary state, both fluxes become equal = Ji. The state flux Ji is, thus, the stationary flux through the node i. To compensate for the dependence of all reaction fluxes on the system size, we normalized all flux values by the total concentration of the GTPase, i.e., ji = Ji/R0. The reaction scheme with n transition fluxes jlm can be represented by the flux vector in the n-dimensional space. The Euclidean distance between two flux vectors 1 and 2 as defined by can be used, for example, as a measure of difference between two states of a reaction scheme. If 2 is taken as a reference flux vector, division of d ( 1, 2) by the Euclidean norm of 2 will give a relative displacement of 1 from 2 in a nondimensional form. We used the normalized Euclidean distance to measure the deviation of the flux vector of the reduced model from that of the complete model (see Results). Figure 6 demonstrates that in the parameter region characterized by efficient GTPase cycling, the difference between the complete and reduced models is less than 5%.
The Euclidean distance between the flux vectors of complete and reduced models was computed as described in Methods and normalized by the magnitude of the flux vector for the complete model. The profile of the normalized distance is shown by thick solid contour lines. The profile of the performance index P (same as Figure 3C) is shown by a thin line for comparison. Note that in the parameter region where the GTPase cycles with a high activity and turnover rate, the difference between the complete and reduced models is 5% or less.
For each reaction l → m it is possible to define a mean transition time tlm = that a molecule spends on average in the transition from node l to m, where is the reaction rate klm for the first-order reactions and is equal to klmX (X = A, E, D, T) for the second-order reactions , e.g., for the chosen earlier example t13 = 1/(k13E) and t31 = 1/k31. Adding up the transition times along any closed loop in the reaction scheme, we obtain a cycling period TC that is required on average to complete the full cycle over the chosen loop. In a stationary state, molecules of each species are continuously synthesized and consumed while their concentrations remain constant. To characterize the time that is necessary for the system in a stationary state to turn over half of the molecules in the node i, we define a recovery time: where Ci and Ji are the stationary concentration and the state flux, respectively. This introduced recovery time is directly comparable with the half-life time measured in the FRAP experiments.
To quantitatively describe the efficiency of the GTPase cycling control in a stationary state, we computed the fractional GTPase activity RT/R0 (in the text it is “activity” for brevity) and the recovery time τRT of the GTPase. Since efficient control is expected to optimize both the activity and the turnover rate, we introduced a single nondimensional performance index: where is a reference recovery time taken to be equal to the recovery time calculated for the spontaneous cycling of the GTPase in vitro (see Results).
Derivation of the analytical estimates for the GTPase activity and recovery time.
Reduction of the GEF–GAP control module to the subset of significant fluxes results in a dramatic simplification of the model and allows us to estimate the GTPase cycling characteristics analytically. As shown in Figure 7, the entire system of reaction fluxes is reduced to three main fluxes: where J1 is the flux through the GEF arm (1 → 3 → 4 → 5 → 2), J2 is the flux through the GAP arm (2 → 6 → 8 → 1), and J3 describes spontaneous transition of RT into RD. From the balance of fluxes in a stationary state, it follows that the stationary flux through RT is given by:
Activation of RD by the GEF or by the GEF-effector complex (E*) is denoted as J1. Inactivation of RT by the GAP and its spontaneous hydrolysis are represented by fluxes J2 and J3, correspondingly. Activation of RD by M is represented by J4 in (B).
Thus, in the parameter domain (E0, A0), where the reduction of the flux system is valid, the recovery time is a sole function of the free concentration of the GAP.
Using the reduced reaction scheme shown in Figure 7A, we also can estimate the activity of the GTPase. Inspection of the simulation results shows that in the parameter domain of interest, the prevalent forms of the GTPase are RT, RD, RDE, and RTE, while the others are practically negligible. In this case, the activity can be defined as: where RDE and RTE can be expressed through the stationary concentrations of RT and RD, using the relationships between the reaction fluxes and species concentrations. For example, since we can express the stationary concentration of the RTE intermediate complex as:
Introducing the notations: we finally obtain the activity in the form presented in Results:
Figure 8 shows that the derived analytical expressions for τRT and RT/R0 correspond well with the numerically simulated values in a broad domain of parameter values.
The activity (upper row) and the recovery time (bottom row) profiles of GTPase are plotted versus the total concentrations of GEF and GAP. Results shown in (A) and (C) were numerically simulated using the complete model, while those shown in (B) and (D) were calculated based on the analytical estimates derived from the reduced model. Note the good match between the simulated and analytically estimated results in a broad domain of parameter values.
Similar estimates can be derived for the M–GAP system where scaffold-effector S forms a stable complex E* with the GEF E. As follows from Figure 7B, in a stationary state, the concentration of M is in a simple relationship with that of the RT: where KM = k2M/kM2 is the binding constant of RT to M. The introduction of M results in an additional flux J4 = k12RD · M that acts in parallel with J1 = k13RD · E*. Since in a stationary state essentially all E* is converted to M, E* << M and J1 << J4. From the balance of fluxes,
This estimate can be used to find the recovery time of the GTPase which is identical to the recovery time in the GEF–GAP module. This result emphasizes that the recovery time is defined by the activity of the GAP alone and, thus, is not affected by the introduction of the scaffold-effector S.
After replacing RT, RD, and M with the corresponding expressions, we obtain the sought-after estimate for the activity of the GTPase in the M–GAP module: whose form is analogous to that for the GEF–GAP system.
National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov) Entrez Protein accession numbers are: cdc42 (AAB40051), cdc42p (NP_013330), CNK1 (AAH12797), COP I (NP_009194), COP II (NP_057535), GAP Bem3 (NP_015210), GEF cdc24p (NP_009359), cdc42p (NP_01333), intersectin-l (NP_003015), Rab5 (AAH09823), Rabaptin-5 (CAA62580), Rac (CAB53579), Rac2 (AAB20524), Ras GTPase (NP_476699), Rho (AAH01360), Sec4p[GTPase]-exocyst[effector]-Sec2p[GEF] (NP_014127), Sos (NP_476597), WASP (AAA62663), and Ypt7p[GTPase]-Vps/HOPS[effector]-Vps39p[GEF] (CAA48244, BAA11758).
ABG and AVP conceived, designed, and performed the experiments; analyzed the data; and wrote the paper.
- 1. Wennerberg K, Rossman KL, Der CJ (2005) The Ras superfamily at a glance. J Cell Sci 118: 843–846.
- 2. Jaffe AB, Hall A (2005) Rho GTPases: Biochemistry and biology. Annu Rev Cell Dev Biol 21: 247–269.
- 3. Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116: 167–179.
- 4. Grosshans BL, Ortiz D, Novick P (2006) Rabs and their effectors: Achieving specificity in membrane traffic. Proc Natl Acad Sci U S A 103: 11821–11827.
- 5. Bishop AL, Hall A (2000) Rho GTPases and their effector proteins. Biochem J 348(Part 2): 241–255.
- 6. Machesky LM, Insall RH (1998) Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol 8: 1347–1356.
- 7. Jaffe AB, Hall A, Schmidt A (2005) Association of CNK1 with Rho guanine nucleotide exchange factors controls signaling specificity downstream of Rho. Curr Biol 15: 405–412.
- 8. Rohatgi R, Ma L, Miki H, Lopez M, Kirchhausen T, et al. (1999) The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell 97: 221–231.
- 9. Watanabe N, Kato T, Fujita A, Ishizaki T, Narumiya S (1999) Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. Nat Cell Biol 1: 136–143.
- 10. Uhlik MT, Abell AN, Johnson NL, Sun W, Cuevas BD, et al. (2003) Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock. Nat Cell Biol 5: 1104–1110.
- 11. Peyker A, Rocks O, Bastiaens PI (2005) Imaging activation of two Ras isoforms simultaneously in a single cell. Chembiochem 6: 78–85.
- 12. Nalbant P, Hodgson L, Kraynov V, Toutchkine A, Hahn KM (2004) Activation of endogenous Cdc42 visualized in living cells. Science 305: 1615–1619.
- 13. Wedlich-Soldner R, Wai SC, Schmidt T, Li R (2004) Robust cell polarity is a dynamic state established by coupling transport and GTPase signaling. J Cell Biol 166: 889–900.
- 14. Kawasaki M, Nakayama K, Wakatsuki S (2005) Membrane recruitment of effector proteins by Arf and Rab GTPases. Curr Opin Struct Biol 15: 681–689.
- 15. McMahon HT, Mills IG (2004) COP and clathrin-coated vesicle budding: Different pathways, common approaches. Curr Opin Cell Biol 16: 379–391.
- 16. Antonny B, Bigay J, Casella JF, Drin G, Mesmin B, et al. (2005) Membrane curvature and the control of GTP hydrolysis in Arf1 during COPI vesicle formation. Biochem Soc Trans 33: 619–622.
- 17. Rybin V, Ullrich O, Rubino M, Alexandrov K, Simon I, et al. (1996) GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature 383: 266–269.
- 18. Vieira OV, Bucci C, Harrison RE, Trimble WS, Lanzetti L, et al. (2003) Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidylinositol 3-kinase. Mol Cell Biol 23: 2501–2514.
- 19. van Bruggen R, Anthony E, Fernandez-Borja M, Roos D (2004) Continuous translocation of Rac2 and the NADPH oxidase component p67(phox) during phagocytosis. J Biol Chem 279: 9097–9102.
- 20. Zhang B, Wang ZX, Zheng Y (1997) Characterization of the interactions between the small GTPase Cdc42 and its GTPase-activating proteins and putative effectors: Comparison of kinetic properties of Cdc42 binding to the Cdc42-interactive domains. J Biol Chem 272: 21999–22007.
- 21. Zhang B, Zhang Y, Wang Z, Zheng Y (2000) The role of Mg2+ cofactor in the guanine nucleotide exchange and GTP hydrolysis reactions of Rho family GTP-binding proteins. J Biol Chem 275: 25299–25307.
- 22. Zheng Y (2001) Dbl family guanine nucleotide exchange factors. Trends Biochem Sci 26: 724–732.
- 23. DerMardirossian C, Bokoch GM (2005) GDIs: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol 15: 356–363.
- 24. Biddlecome GH, Berstein G, Ross EM (1996) Regulation of phospholipase C-beta1 by Gq and m1 muscarinic cholinergic receptor: Steady-state balance of receptor-mediated activation and GTPase-activating protein-promoted deactivation. J Biol Chem 271: 7999–8007.
- 25. Mukhopadhyay S, Ross EM (1999) Rapid GTP binding and hydrolysis by G(q) promoted by receptor and GTPase-activating proteins. Proc Natl Acad Sci U S A 96: 9539–9544.
- 26. Yi TM, Kitano H, Simon MI (2003) A quantitative characterization of the yeast heterotrimeric G protein cycle. Proc Natl Acad Sci U S A 100: 10764–10769.
- 27. Mahama PA, Linderman JJ (1994) A Monte Carlo study of the dynamics of G-protein activation. Biophys J 67: 1345–1357.
- 28. Zhong H, Wade SM, Woolf PJ, Linderman JJ, Traynor JR, et al. (2003) A spatial focusing model for G protein signals: Regulator of G protein signaling (RGS) protein-mediated kinetic scaffolding. J Biol Chem 278: 7278–7284.
- 29. Hao N, Yildirim N, Wang Y, Elston TC, Dohlman HG (2003) Regulators of G protein signaling and transient activation of signaling: Experimental and computational analysis reveals negative and positive feedback controls on G protein activity. J Biol Chem 278: 46506–46515.
- 30. Bornheimer SJ, Maurya MR, Farquhar MG, Subramaniam S (2004) Computational modeling reveals how interplay between components of a GTPase-cycle module regulates signal transduction. Proc Natl Acad Sci U S A 101: 15899–15904.
- 31. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629–635.
- 32. Coleman ML, Marshall CJ, Olson MF (2004) RAS and RHO GTPases in G1-phase cell-cycle regulation. Nat Rev Mol Cell Biol 5: 355–366.
- 33. Fukata M, Nakagawa M, Kaibuchi K (2003) Roles of Rho-family GTPases in cell polarisation and directional migration. Curr Opin Cell Biol 15: 590–597.
- 34. Sahai E, Marshall CJ (2002) RHO-GTPases and cancer. Nat Rev Cancer 2: 133–142.
- 35. Dovas A, Couchman JR (2005) RhoGDI: Multiple functions in the regulation of Rho family GTPase activities. Biochem J 390: 1–9.
- 36. Ali BR, Seabra MC (2005) Targeting of Rab GTPases to cellular membranes. Biochem Soc Trans 33: 652–656.
- 37. Hussain NK, Jenna S, Glogauer M, Quinn CC, Wasiak S, et al. (2001) Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP. Nat Cell Biol 3: 927–932.
- 38. Lippe R, Miaczynska M, Rybin V, Runge A, Zerial M (2001) Functional synergy between Rab5 effector Rabaptin-5 and exchange factor Rabex-5 when physically associated in a complex. Mol Biol Cell 12: 2219–2228.
- 39. Terasawa H, Noda Y, Ito T, Hatanaka H, Ichikawa S, et al. (2001) Structure and ligand recognition of the PB1 domain: A novel protein module binding to the PC motif. EMBO J 20: 3947–3956.
- 40. Bose I, Irazoqui JE, Moskow JJ, Bardes ES, Zyla TR, et al. (2001) Assembly of scaffold-mediated complexes containing Cdc42p, the exchange factor Cdc24p, and the effector Cla4p required for cell cycle-regulated phosphorylation of Cdc24p. J Biol Chem 276: 7176–7186.
- 41. Graham DL, Lowe PN, Chalk PA (2001) A method to measure the interaction of Rac/Cdc42 with their binding partners using fluorescence resonance energy transfer between mutants of green fluorescent protein. Anal Biochem 296: 208–217.
- 42. Hemsath L, Dvorsky R, Fiegen D, Carlier MF, Ahmadian MR (2005) An electrostatic steering mechanism of Cdc42 recognition by Wiskott–Aldrich syndrome proteins. Mol Cell 20: 313–324.
- 43. Dransart E, Olofsson B, Cherfils J (2005) RhoGDIs revisited: Novel roles in Rho regulation. Traffic 6: 957–966.
- 44. Koch G, Tanaka K, Masuda T, Yamochi W, Nonaka H, et al. (1997) Association of the Rho family small GTP-binding proteins with Rho GDP dissociation inhibitor (Rho GDI) in Saccharomyces cerevisiae. Oncogene 15: 417–422.
- 45. Medkova M, France YE, Coleman J, Novick P (2006) The rab exchange factor Sec2p reversibly associates with the exocyst. Mol Biol Cell 17: 2757–2769.
- 46. Seals DF, Eitzen G, Margolis N, Wickner WT, Price A (2000) A Ypt/Rab effector complex containing the Sec1 homolog Vps33p is required for homotypic vacuole fusion. Proc Natl Acad Sci U S A 97: 9402–9407.
- 47. Wurmser AE, Sato TK, Emr SD (2000) New component of the vacuolar class C-Vps complex couples nucleotide exchange on the Ypt7 GTPase to SNARE-dependent docking and fusion. J Cell Biol 151: 551–562.
- 48. Margarit SM, Sondermann H, Hall BE, Nagar B, Hoelz A, et al. (2003) Structural evidence for feedback activation by Ras-GTP of the Ras-specific nucleotide exchange factor SOS. Cell 112: 685–695.
- 49. Niggli V (2005) Regulation of protein activities by phosphoinositide phosphates. Annu Rev Cell Dev Biol 21: 57–79.
- 50. Downes CP, Gray A, Fairservice A, Safrany ST, Batty IH, et al. (2005) The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups. Biochem Soc Trans 33: 1303–1307.
- 51. Pawson T, Nash P (2003) Assembly of cell regulatory systems through protein interaction domains. Science 300: 445–452.
- 52. Schlessinger J (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211–225.
- 53. Wedlich-Soldner R, Altschuler S, Wu L, Li R (2003) Spontaneous cell polarization through actomyosin-based delivery of the Cdc42 GTPase. Science 299: 1231–1235.
- 54. Ozbudak EM, Becskei A, van Oudenaarden A (2005) A system of counteracting feedback loops regulates Cdc42p activity during spontaneous cell polarization. Dev Cell 9: 565–571.
- 55. Traut TW (1994) Physiological concentrations of purines and pyrimidines. Mol Cell Biochem 140: 1–22.
- 56. Hill TL (1989) Free energy transduction and biochemical cycle kinetics. New York: Dover Publications. 128 p.
- 57. Schmidt H, Jirstrand M (2006) Systems Biology Toolbox for MATLAB: A computational platform for research in Systems Biology. Bioinformatics 22: 514–515.
- 58. Zhang B, Zhang Y, Collins CC, Johnson DI, Zheng Y (1999) A built-in arginine finger triggers the self-stimulatory GTPase-activating activity of rho family GTPases. J Biol Chem 274: 2609–2612.
- 59. Zheng Y, Bender A, Cerione RA (1995) Interactions among proteins involved in bud-site selection and bud-site assembly in Saccharomyces cerevisiae. J Biol Chem 270: 626–630.
- 60. Zheng Y, Hart MJ, Shinjo K, Evans T, Bender A, et al. (1993) Biochemical comparisons of the Saccharomyces cerevisiae Bem2 and Bem3 proteins: Delineation of a limit Cdc42 GTPase-activating protein domain. J Biol Chem 268: 24629–24634.